Davis Capital Management’s Arcus Biosciences RCUS Stock Holding History

Davis Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123	Buy	+4	New	+$99	﹤0.01%	1014

Other funds holding RCUS

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Davis Capital Management's RCUS Position: Q2 2026 in Review

Davis Capital Management opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 4 shares worth $123. The stake represents ﹤0.01% of the portfolio and ranks #1014 among its holdings.

29 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Davis Capital Management held 4 shares of Arcus Biosciences worth $123 as of Q2 2026.
Arcus Biosciences was a new Davis Capital Management position in Q2 2026.
Arcus Biosciences made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1014 holding.
29 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.